日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Shared Local Oncology Care After Allogeneic Hematopoietic Cell Transplantation: A Randomized Clinical Trial

异基因造血干细胞移植后共享本地肿瘤护理:一项随机临床试验

Abel, Gregory A; Kim, Haesook T; Zackon, Ira; Alyea, Edwin T; Bailey, Alexandra S; Winters, John P; Meehan, Kenneth R; Reagan, John L; Walsh, Jeanna H; Walsh, Thomas P; Ivanov, Alexandra; Faggen, Meredith A; Sinclair, Sarah; Joyce, Amy C; Close, Sara D; Emmert, Amy; Koreth, Jon; Antin, Joseph H; Cutler, Corey S; Ho, Vincent T; Soiffer, Robert J

Nonspecific Signs and/or Symptoms of Cancer: A Retrospective, Observational Analysis from a Secondary Care, US Community Oncology Dataset

癌症的非特异性体征和/或症状:一项基于美国二级医疗机构社区肿瘤数据集的回顾性观察分析

Benton, Christopher B; He, Ding; Todoroff, Karen; Coignet, Marie V; Luan, Ying; Wong, Jason C; Kurtzman, Kathryn N; Zackon, Ira

Lack of Efficacy of Suvorexant in People with Insomnia and Poorly Controlled Type 2 Diabetes

舒沃雷生对失眠和血糖控制不佳的2型糖尿病患者疗效不佳

Winkelman, John W; Wipper, Benjamin; Zackon, Jordana; Hoeppner, Bettina B

A Phase I/II Study of Evofosfamide, A Hypoxia-activated Prodrug with or without Bortezomib in Subjects with Relapsed/Refractory Multiple Myeloma

一项针对复发/难治性多发性骨髓瘤患者的 I/II 期研究,评估缺氧激活前药 Evofosfamide 联合或不联合硼替佐米的疗效。

Laubach, Jacob P; Liu, Chia-Jen; Raje, Noopur S; Yee, Andrew J; Armand, Philippe; Schlossman, Robert L; Rosenblatt, Jacalyn; Hedlund, Jacquelyn; Martin, Michael; Reynolds, Craig; Shain, Kenneth H; Zackon, Ira; Stampleman, Laura; Henrick, Patrick; Rivotto, Bradley; Hornburg, Kalvis T V; Dumke, Henry J; Chuma, Stacey; Savell, Alexandra; Handisides, Damian R; Kroll, Stew; Anderson, Kenneth C; Richardson, Paul G; Ghobrial, Irene M

Maximizing the effectiveness of oral therapies in lymphoid cancers: research gaps and unmet needs

最大限度地提高口服疗法在淋巴瘤治疗中的疗效:研究空白和未满足的需求

Zackon, Alix Y L; Ayers, Amy A; Yeager, Katherine A; Somma, Mary L; Friedberg, Jonathan W; Flowers, Christopher R; Nastoupil, Loretta J